-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G7k8ucZ7GGTo7veAbU7mhjTSL0v8WH/Y9JQtTlP3/zlNBa7QTkvQWpu2f4vb4eX8 P/wuwgDOZ9NVHxY6UttNAA== 0001218821-04-000005.txt : 20040701 0001218821-04-000005.hdr.sgml : 20040701 20040701163945 ACCESSION NUMBER: 0001218821-04-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040630 FILED AS OF DATE: 20040701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THOMPSON VIRGIL CENTRAL INDEX KEY: 0001218821 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 04895702 MAIL ADDRESS: STREET 1: 319 SOUTH NARDO CITY: SOIANA BEACH STATE: CA ZIP: 92075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2004-06-30 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218821 THOMPSON VIRGIL 755 BARBARA AVENUE SOLANA BEACH CA 92075 1 0 0 0 Common stock, $.01 par value per share 2004-06-30 4 A 0 1008 2.48 A 21650 D Options to purchase common stock, $.01 par value per share 2.48 2004-06-30 4 A 0 5000 2.48 A 2005-06-30 2014-06-30 Common stock, $01 par value per share 5000 100000 D These shares were granted pursuant to the Company's Stock Compensation Plan for Outside Directors, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $2,500, until he is no longer an Outside Director. On June 30, 2004, the fair market value of the Common Stock, based on the closing price, was $2.48 These options will become fully vested and immediately exercisable on 06/30/2005. Beata Smith as Attorney-in-Fact for Virgil Thompson 2004-07-01 -----END PRIVACY-ENHANCED MESSAGE-----